Health Care

J.M. Smucker Co. is recalling select Hostess Ding Dongs products due to potential mold contamination caused by a mechanical issue during manufacturing

Johnson & Johnson announces a $2 billion North Carolina manufacturing expansion as part of a broader U.S. onshore biopharmaceutical initiative that will create new jobs.

Whistleblower Sarah Behnke's lawsuit leads to a $290 million judgment against CVS Caremark for overcharging Medicare on prescription drugs in 2013 and 2014.

Cash-paying type 2 diabetes patients in the United States can now access Novo Nordisk's Ozempic for $499 per month through multiple pharmacy platforms.

Berkshire Hathaway's $1.6 billion stake in UnitedHealth Group is helping to lift the Dow Jones Industrial Average to a new record as investors pile into healthcare sector funds.

Federal health officials are warning sunscreen companies for violating drug regulations by selling products in unapproved whipped, mousse and foam forms.

Boar's Head established a food safety council and appoints a new safety officer the company prepares to reopen its Virginia plant that was linked to deadly listeria outbreak.

The Food and Drug Administration could pull Pfizer's coronavirus vaccine emergency authorization for children under age 5.

OpenAI CEO Sam Altman says GPT-5 could save lives as a physician assistant and unlock a $100B business opportunity across industries by boosting productivity.

FTC reaches $145 million settlement with Assurance IQ and MediaAlpha over allegations of misleading consumers about healthcare services and illegal robocalls.

Pharmaceutical CEOs are on notice about sky-high drug prices as President Donald Trump demands a recalibration of what Americans are paying compared to other countries.

Massachusetts-based Moderna said it plans to cut 10% of its global staff as part of its ongoing efforts to reduce annual operating expenses by around $1.5 billion by 2027.

A Fidelity study shows 65-year-old retirees need $172,500 for healthcare costs, with Medicare coverage gaps requiring supplemental insurance planning.

The Trump administration launched an FTC probe into whether healthcare providers misrepresent risks of transgender procedures for minors on Monday.